Latest Amyloid precursor protein Stories
A research team composed of University of Kentucky researchers has published a paper which provides the first direct evidence that activated astrocytes could play a harmful role in Alzheimer's disease.
An interdisciplinary team of Japanese and Canadian scientists have shown that a drug intended for diabetes appears to restore memory in Alzheimer's-affected brain cells.
Scientists from VIB and KU Leuven have discovered a new target molecule for the development of a treatment against Alzheimer's disease.
Alzheimer's disease is one of the most common causes of dementia.
Growing evidence suggests that there may be a link between diabetes and Alzheimer's disease, but the physiological mechanisms by which diabetes impacts brain function and cognition are not fully understood.
Researchers at Washington University School of Medicine in St. Louis have found a key difference in the brains of people with Alzheimer's disease and those who are cognitively normal but still have brain plaques that characterize this type of dementia.
Neuroscientists at the University of Rochester Medical Center found a system that can drain the waste from the brain; it was previously unrecognized by scientists.
Scientists at the Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer's-related impairments in an animal model of the disease.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).